A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial
Bengt I. Eriksson, O.E. Dahl, Harry R. Büller, Rohan Hettiarachchi, Nadia Rosencher, M-L. BRAVO, Lennart Ahnfelt, Franco Piovella, Joachim Stangier, P. KÄLEBO, P. Reilly
Journal of Thrombosis and Haemostasis, 2004
Abstract
An abstract is not available for this record. Please visit the publisher website for more details.